I am a Physician (practicing Child Psychiatry) and I have been an investor in Cytokinetics (NASDAQ:CYTK) for approximately 16 months. While this is my first Seeking Alpha article, I have contributed my thoughts more briefly to StockTwits during that time. I intend to contribute more regularly to Seeking Alpha as a way of more fully explaining my ideas. While CYTK is one of my more prominent holdings, I follow several other Biotech stocks as well as some technical/value plays.
Two Studies Which Did Not Meet Primary End Point
Omecamtiv Mecarbil ATOMIC Study
ATOMIC-AHF was a Phase 2b study of an IV form of Omecamtiv Mecarbil (OM) for which results were presented at the European Society of...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|